ProMIS Neurosciences Statistics Share Statistics ProMIS Neurosciences has 32.69M
shares outstanding. The number of shares has increased by 9.38%
in one year.
Shares Outstanding 32.69M Shares Change (YoY) 9.38% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 22.81M Failed to Deliver (FTD) Shares 1,904 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 1.77M, so 5.41% of the outstanding
shares have been sold short.
Short Interest 1.77M Short % of Shares Out 5.41% Short % of Float 5.52% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is 0.01 and the forward
PE ratio is -0.73.
ProMIS Neurosciences's PEG ratio is
0.
PE Ratio 0.01 Forward PE -0.73 PS Ratio 0 Forward PS n/a PB Ratio 0 P/FCF Ratio -0.9 PEG Ratio 0
Financial Ratio History Enterprise Valuation ProMIS Neurosciences has an Enterprise Value (EV) of 11.28M.
EV / Sales 0 EV / EBITDA 0 EV / EBIT -0.41 EV / FCF -0.41
Financial Position The company has a current ratio of 8.52,
with a Debt / Equity ratio of 0.
Current Ratio 8.52 Quick Ratio 8.52 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 219.18
Financial Efficiency Return on Equity is 16.85% and Return on Invested Capital is -100805.41%.
Return on Equity 16.85% Return on Assets 14694.13% Return on Invested Capital -100805.41% Revenue Per Employee n/a Profits Per Employee $396.98M Employee Count 7 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -50.82% in the
last 52 weeks. The beta is -0.03, so ProMIS Neurosciences's
price volatility has been lower than the market average.
Beta -0.03 52-Week Price Change -50.82% 50-Day Moving Average 0.57 200-Day Moving Average 0.76 Relative Strength Index (RSI) 44.35 Average Volume (20 Days) 7,001,770
Income Statement
Revenue n/a Gross Profit n/a Operating Income -16.83B Net Income 2.78B EBITDA -16.83B EBIT 2.7B Earnings Per Share (EPS) 0.11
Full Income Statement Balance Sheet The company has 13.29M in cash and 0 in
debt, giving a net cash position of 13.29M.
Cash & Cash Equivalents 13.29M Total Debt n/a Net Cash n/a Retained Earnings -90.69B Total Assets 13.65M Working Capital 9.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -27.18M
and capital expenditures 0, giving a free cash flow of -27.18M.
Operating Cash Flow -27.18M Capital Expenditures n/a Free Cash Flow -27.18M FCF Per Share -1.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PMN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 11311.43% FCF Yield -110.65%
Dividend Details Analyst Forecast The average price target for PMN is $4,
which is 566.7% higher than the current price. The consensus rating is "Buy".
Price Target $4 Price Target Difference 566.7% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 1238.73 Graham Upside 206355%
Stock Splits The last stock split was on Jun 28, 2022. It was a
backward
split with a ratio of 1:60.
Last Split Date Jun 28, 2022 Split Type backward Split Ratio 1:60
Scores Altman Z-Score -12.73 Piotroski F-Score 1
